Earn credits and unlock exclusive offers with iXCells Loyalty Program!


Induced Pluripotent Stem Cells (iPSCs) engineering to drive innovation in drug discovery, drug screening, disease modeling, personalized medicine, and preclinical cell regeneration projects.


iPSC-Based Solutions For Drug Discovery & Development

Leveraging induced Pluripotent Stem Cells (iPSCs) engineering to advance drug discovery, drug screening, disease modeling, personalized medicine, and preclinical cell regeneration projects.

Our dedicated team of iPSCs experts generates high-quality cells that are robust, karyotype-normal, exhibit pluripotency, and derived from physiologically relevant cell line models from both healthy and disease human or non-human samples.

iPSC Reprogramming

Donor cell types: Fibroblasts, PBMCs, LCLs
Integration-free protocols: Episomal, Sendai virus
Fast Turnaround: 2-3 months
High Success Rate: >95%
Comprehensive QC
  • Freeze-thaw viability
  •  Morphology
  • AP staining
  • ICC staining for pluripotency markers
  • Karyotyping: G-banding, KaryoStatTM
  • Optional: PluriTest, Scorecard

What Our Clients Say About us


Fast Turnaround & tailored to your needs

Fast Turnaround & tailored to your needs

We can generate high- quality iPSCs in 2-3 months. Highly optimized, high-efficiency protocols ideal for iPSC banking/ iPSC repositories (~95% success rate)
Highly optimized protocols

Highly optimized protocols

High-quality, induced pluripotent stem cells (iPSC) and derived physiologically relevant cell line models from healthy or disease human or non-human samples with high reprogramming efficiency (>95% success rate).
iPSC generation from various donor cell types

iPSC generation from various donor cell types

Custom human and non-human iPSC generation: PBMCs, fibroblasts, MSCs, CD34+ cord blood, and more.
Integration-free & Feeder-free

Integration-free & Feeder-free

Our pipeline is built to meet your project and assay-specific requirements for cellular characteristics and functionality.Integration-free: Episomal/Sendai virus/mRNA. Feeder-dependent protocols available.



Service Description Catalog #
Derivation and cryopreservation of skin fibroblast CSIP – 01
Derivation and cryopreservation of PBMCs CSIP – 02
Human pathogen panel screening CSIP – 03
iPSC generation (without colony pickup) CSIP – 04
Single colony isolation, expansion and cryopreservation CSIP – 05
Pluripotency marker staining (4 markers) CSIP – 06
In vitro three germ layer differentiation (2 markers/lineage) CSIP – 07
In vivo differentiation (teratoma formattino under kidney capsule) CSIP – 08


  • Contact us for free consultation.
  • Guaranteed iPSC generation (>3 integration free clones).
  • Scheduled milestone.
  • Comprehensive characterization of the established iPSCs clones.
  • Characterization data in Publication-ready format.

Explore Other Services

Frequently Asked Questions (FAQ's)

You will need to fill in the questionnaire form. Briefly you will need to provide the cells to be reprogrammed, the culture protocol if specified, and the validation methods if specified.

For Fibroblast: Two vials of frozen cells or one T25 flask of live cell, or fresh tissue biopsy preserved in cell culture media less than 7 days.

For PBMCs: Two vials of frozen PBMCs or 2-5ml fresh whole blood stored at 4C less than 4 days.

Cells from us: We also provide a wide collection of primary cells for the customers to choose from.

The customer should provide pathogen screening result. If not, iXCells Biotechnologies will perform the pathogen screening before reprogramming.

It takes 3-6 months depending on the recovery of the cells provided by the customer, cell type to be reprogrammed, and validation assays requested by the customer.

We will ship 3 frozen vials of each clone to the customer. Live cultures are available upon requests.

We will also provide characterization data in publication-ready format.

We will provide 1) the reprogramming method we used to generate the cell line; 2) the recovery and maintenance method after you receive the cells; 3) Cell recovery and live culture delivery if desired; 4) in-house training course if desired.